FINATI, ELENA
FINATI, ELENA
Universita' degli Studi di MILANO
Different routes and formulations of melatonin in critically ill patients : a pharmacokinetic randomized study
2019 G. Mistraletti, R. Paroni, M. Umbrello, B. Moro Salihovic, S. Coppola, S. Froio, E. Finati, P. Gasco, A. Savoca, D. Manca, D. Chiumello, R.J. Reiter, G. Iapichino
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV
2018 A. Karampatou, X. Han, L.A. Kondili, G. Taliani, A. Ciancio, F. Morisco, R.M. Critelli, E. Baraldi, V. Bernabucci, G. Troshina, M. Guarino, S. Tagliavini, F. D'Ambrosio, L. Bristot, L. Turco, S. Rosato, S. Vella, T. Trenti, I. Neri, A. La Marca, S. Manthena, A.S. Goldstein, S. Bruno, Y. Bao, Y.S. Gonzalez, E. Villa, A. Craxi, S. Petta, V. Calvaruso, M. Brunetto, B. Coco, L. Chessa, M.C. Pasetto, E. Bigliotti, F. Tamburrini, G. Montalto, A.R. Capitano, D. Ieluzzi, G. Fattovich, A.L. Zignego, M. Monti, L. Gragnani, M. Zuin, E. Finati, A. Giorgini, G. Angarano, M. Milella, F. Alessandro, M. Dallio, G. Mazzella, G. Lazzarini, M. Di Fine, F.P. Russo, A. Zanetto, F. Castelli, S. Zaltron, G. Raimondo, R. Filomia, M. Puoti, E. Danieli, M. Strazzabosco, M. Gemma, M. Angelico, F. De Leonardis, A. Gori, E. Cappelletti, R. Bruno, S. Cima, C. Coppola, D.C. Amoruso, P. Andreone, G. Simonetti, G.B. Gaeta, G. Brancaccio, P. Toniutto, D. Dissegna, M. Mondelli, S. Ludovisi, M. Persico, M. Masarone, C. Torti, A. Strazzulla, F. Rosina, L. Framarin, L.E. Weimer, M.G. Quaranta, L. Falzano, A. Mallano
Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer
2017 L. Terraneo, P. Bianciardi, E. Virgili, E. Finati, M. Samaja, R. Paroni
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling
2014 R. Paroni, L. Terraneo, F. Bonomini, E. Finati, E. Virgili, P. Bianciardi, G. Favero, F. Fraschini, R.J. Reiter, R. Rezzani, M. Samaja
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm
2013 E. Finati, G. Mistraletti, G. Iapichino, F. Fraschini, R. Paroni
Novel strategies to deliver melatonin (in SLN and by cryo-laser therapy) to prostate cancer cells
2013 E. Finati, E. Virgili, L. Terraneo, F. Bonomini, P. Bianciardi, R. Rezzani, M. Samaja, R. Paroni
MELATONIN: A PLEIOTROPIC MOLECULE OF NATURAL ORIGIN. EVALUATION OF THE DIFFERENT THERAPEUTIC ACTIVITIES IN ANIMAL MODELS AND / OR HUMAN PATIENTS AND A STUDY OF THE METABOLIC-BIOCHEMICAL PATHWAYS RELATED TO THEM.
2013 E. Finati
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN)
2012 B. Salihovic, F. Ferrari, G. Mistraletti, E. Mantovani, R.C. Paroni, E. Finati, F.L. Fraschini, I. Galluccio, B. Cerri, S. Marzorati, G. Iapichino
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction
2012 R. Paroni, A. Barassi, F. Ciociola, E. Dozio, E. Finati, I. Fermo, F. Ghilardi, G.M. Colpi, M.M. Corsi, G.V. Melzi d'Eril
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation
2011 L. Terraneo, E. Finati, E. Virgili, G. Demartini, L. De Angelis, R. Dall'Aglio, F.L. Fraschini, M. Samaja, R.C. Paroni
Novel strategies to deliver melatonin (in SLN and as cryo-laser therapy) to prostate cancer cells in vivo
2010 R. Paroni, E. Finati, L. Terraneo, D. Oldani, G. Demartini, L. De Angelis, F. Fraschini, M. Samaja